Stocks
Constellation Pharmaceuticals (CNST) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 2 941% | 5 604% | 10 246% | 9 508% | 10 095% | 7 597% | |||
| Changes by years, y/y, % | +2 663pp | +4 641pp | -738pp | +588pp | +36.1% | ||||
Constellation Pharmaceuticals. R&D/CAPEX, %
Constellation Pharmaceuticals. R&D/CAPEX, changes, pp
Constellation Pharmaceuticals (CNST) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2020Q1 | 2020Q2 | 2020Q3 | 2020Q4 | 2021Q1 | LTM ? | |||
| R&D/CAPEX, % | 52 829% | 18 396% | 3 939% | 19 681% | 6 282% | 7 597% | ||
| Changes by years, y/y, % | +46 129pp | +11 607pp | -3 651pp | -96 482pp | -46 546pp | |||
| Changes by quarters, q/q, % | -63 334pp | -34 433pp | -14 457pp | +15 742pp | -13 398pp | |||
